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Summary Introduction
Many microdeletion and contiguous gene–deletion syn-
Developmental delay and/or mental retardation aredromes include mental retardation as a clinical feature. We
common clinical indications for chromosomal studieshave developed MultiFISH, a FISH assay using several
and constitute a large portion of referrals for cytogeneticprobes to simultaneously screen for multiple microdeletion
analysis. Although developmental delay or mental retar-syndromes in patients who present with unexplained devel-
dation may be seen without associated features, eachopmental delay and/or mental retardation. This screening
may also occur as part of recognizable deletion syn-tool can be used to determine whether a particular microde-
dromes. Several microdeletion syndromes have been de-letion syndrome is involved in the etiology of these clinical
scribed to date, including Williams syndrome (WS) (de-phenotypes. In this pilot study we combined probes for
letion of 7q11.23), Prader-Willi syndrome (PWS) andthe commonly deleted regions of Prader-Willi, Angelman,
Angelman syndrome (AS) (deletion of 15q12), Smith-Williams, Smith-Magenis, and DiGeorge/velocardiofacial
Magenis syndrome (SMS) (deletion of 17p11.2), andsyndromes in a single hybridization. The probes were differ-
DiGeorge/velocardiofacial syndromes (DGS/VCFS) (de-entially labeled, allowing multicolor detection, and 200 indi-
letion of 22q11.2). The majority of patients with thesevidual samples were screened in a blinded fashion. For all
syndromes have demonstrated deletions at the respectivepatients found by MultiFISH to have deletions, the deletions
critical regions. Many of these are submicroscopic dele-were originally identified and/or later confirmed by use of
tions, at or below the level of cytogenetic resolution,single-probe FISH analysis in our diagnostic cytogenetics
requiring molecular methodologies for their optimal vi-laboratory. One patient, who was referred for develop-
sualization. Some of these microdeletion syndromes aremental delay and was shown to have a normal G-banded
caused by inactivation of a single gene (e.g., Rubinstein-karyotype, was identified by MultiFISH as having a micro-
Taybi syndrome); others almost certainly involve multi-deletion at the DiGeorge/velocardiofacial commonly de-
ple genes and can be considered contiguous gene–dele-leted region. Forty-six of the 200 total samples were tested
tion syndromes (e.g., WS); and others involve an un-for microdeletions by use of single FISH probes in the diag-
known number of genes (e.g., SMS or DGS/VCFS)nostic laboratory. Ten of these cases were found to have
(Greenberg et al. 1991; Driscoll et al. 1992; Ewart etdeletions, and all deletions were subsequently detected by
al. 1993; Nickerson et al. 1995; Frangiskakis et al. 1996;use of a MultiFISH screen performed in a blinded fashion.
Tassabehji et al. 1996). For some disorders, such as PWSAdditionally, for all 200 patients tested by use of
or Rubinstein-Taybi syndrome, only a fraction of theMultiFISH, no false-positive deletion results were observed.
patients have a large deletion detectable by routine cyto-We demonstrate the ability of this technique to scan for
genetics or by FISH, and the remainder have other mo-and to identify microdeletions in a proportion of patients
lecular lesions (Breuning et al. 1993; Petrij et al. 1995;whose routine karyotype appears normal yet who are men-
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cantly more patient material, compared with single-
probe FISH.
We report here the use of MultiFISH—multiple, si-
multaneous, fluorescently labeled probes for testing mi-
crodeletion syndromes—in a study of 200 chromosomal
samples referred to our laboratory, for one of several
indications, including developmental delay, mental re-
tardation, or fragile X or specifically to exclude a partic-
ular microdeletion syndrome. The purpose of this study
was to develop a FISH assay that tested multiple loci
simultaneously, to determine whether any of the patients
referred with nonspecific indications for cytogenetic
analysis could be identified as having a known microde-
letion syndrome. MultiFISH was performed by use of a
cocktail of probes that are routinely used individually
to detect deletions in the WS, PWS, AS, SMS, and DGS/
VCFS regions. MultiFISH successfully detected patients
with previously identified microdeletions and also re-
vealed a deletion in a single patient, referred for develop-
mental delay and mental retardation, for whom no spe-
cific genetic disorder was suspected. The work presented
here demonstrates that a multiple-probe cocktail, in-
cluding cosmids corresponding to the critical regions of
several deletion syndromes, can be used successfully to
identify microdeletions that may otherwise go unde-
tected in a proportion of patients presenting with devel-
opmental delay and/or mental retardation.
Figure 1 Four patients carrying microdeletions corresponding
to syndromes represented in the MultiFISH cocktail. Diagnoses are
Material and Methodsprovided in the appendix.
Samples
Patient samples were obtained through referrals madephysical features alone (Lindsay et al. 1995; Greenberg
to the Kleberg Cytogenetics Laboratory (Baylor Collegeet al. 1996). Furthermore, some features are so subtle
of Medicine), for FISH to exclude a particular microde-as to elude detection even when they are present. This
letion syndrome (n  45) or for routine banded karyo-increases the difficulty of clinical identification in pa-
types for indications including developmental delay and/tients who present with unexplained developmental de-
or mental retardation (n  155) (see table 1). In addi-lay and/or mental retardation, both of which can be
tion, metaphases from four normal individuals (con-characteristic of multiple syndromes. Shown in figure 1
trols) were hybridized with each of the four individualare four patients, each of whom carries a microdeletion
probes to be included in the MultiFISH cocktail, in ordercorresponding to one of the syndromes represented in
to establish the single-probe hybridization efficiencies.the MultiFISH cocktail. To illustrate the potential clini-
Metaphase spreads were prepared by use of standardcal difficulty of diagnosing these patients, their respec-
cytogenetic procedures. Cell pellets prepared from lym-tive syndromes are not revealed in the legend accompa-
phocyte cultures were resuspended in an appropriatenying figure 1 but can be found in an appendix at the
volume of fixative (75% methanol, 25% acetic acid)end of the main text of this paper. If a particular micro-
prior to preparation of the slides. Slides were floodeddeletion is suspected by the clinician, then the presence
with fixative solution, and the cells were then appliedor absence of that deletion can be tested in a cytogenetics
with a pasteur pipet while the slides were held at approx-laboratory using FISH (reviewed in Shaffer 1995). How-
imately a 307 angle. The slides were dried at room tem-ever, if several different deletion syndromes appear in
perature over a period of 5 min and then were checked,the differential diagnosis, the corresponding analyses
by phase microscopy, for a sufficient number of meta-would require a number of sequential hybridizations
phases. Slides were then coded by a cytotechnologistusing the appropriate individual probes. These sequen-
and were entered into the study. If not used immediately,tial analyses are relatively expensive, consume a great
deal of technician time and reagents, and require signifi- the slides were stored at 0207C.
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Table 1 ml of either digoxigenin 11-dUTP or biotin 16-dUTP
[final volume 120 ml] [Boehringer Mannheim]), 4 ml of
Summary of MultiFISH Results
10 1 nick-translation buffer (500 mM Tris pH 7.5, 10
mM DTT, 100 mM MgCl2), 2 ml of DNA polymeraseNo. of Patients Deleted by MultiFISH/
Indicationa Total No. of Patients Tested I (5 U/ml stock), and 3.2 ml of a 1:250 dilution of DNase
I (1 mg/ml stock). Reactions were vortexed briefly to
DDMR/FRAXb 1/155 combine them and then were spun to collect them. Nick-
Exclude WSc 4/9
translation reactions were performed at 157C for 1 hExclude ASd 0/8
and then were stopped by addition of 2 ml of 0.5 MExclude PWSe 1/7
Exclude SMS 2/7 EDTA and heat inactivation at 657C for 10 min. Com-
Exclude DGS/VCFS 3/13 pleted reactions were then vortexed to combine the
Exclude MDSf 0/1 EDTA and were spun down and stored at 47C. Precipita-
tions included the following cosmids (final concentra-a DDMR  developmental delay and/or mental retardation; FRAX
tions in the MultiFISH cocktail are given in parentheses): fragile X syndrome; and MDS  Miller-Dieker syndrome.
b Includes cases referred for multiple congenital anomalies as well cELN272-DIG label (35 ng/ml), C102-DIG label (15 ng/
as for dysmorphism. ml), C102-BIOTIN label (15 ng/ml), C106-DIG label (15
c Includes 1 patient also referred to exclude VCFS. ng/ml), C106-BIOTIN label (15 ng/ml), F5-BIOTIN labeld Includes joint referrals to exclude VCFS (1 patient), PWS (1
(20 ng/ml), SMS92C10-DIG label (15 ng/ml), andpatient), FRAX (1 patient), SMS (1 patient) and Rett syndrome (1
SMS62F2-DIG label (15 ng/ml), plus 20 ml of sonicatedpatient).
e Includes referrals to exclude AS (1 patient). salmon sperm DNA (10 mg/ml stock), 15 ml of Cot-1
f A specific probe for MDS was not included in the MultiFISH DNA (1 mg/ml stock), and 400 ml of 100% ethanol.
cocktail. After precipitation, the pellets were washed with 70%
ethanol and then were dried. Pellets were resuspended
in either 10 ml (half slide; 1 1 probe) or 20 ml (full
Probe Descriptions slide; 1 1 probe) of 50% hybridization buffer (50%
formamide, 10% 20 1 SSC, 10% dextran sulfate).Cosmid cELN272 mapping to chromosome 7q11.23
(Ewart et al. 1993) corresponds to the 5* portion of
Slide Denaturation and Hybridizationthe elastin gene and detects deletions in 90% of WS
Prior to hybridization, the slides were dehydrated inpatients (Nickerson et al. 1995). Cosmids c102 and
a series of ethanol washes (70%, 90%, and 95%, for 2c106, which identify the SNRPN locus (Nakao et al.
min each) and then were air dried. Slides were denatured1994), were combined to identify deletions in 15q12, in
in 70% formamide, 2 1 SSC at 707C for 2 min (plusthe PWS/AS region. Cosmid F5 (Lindsay et al. 1995)
17C for every additional slide) in coplin jars. Denaturedidentifies the commonly deleted DGS/VCFS region at
slides were immediately immersed in ice-cold 70% etha-22q11.2. Cosmids cSMS92C10 and cSMS62F2, map-
nol for 2 min, followed by successive 2-min washes inping to the FLI locus (Chen et al. 1995), were combined
ice-cold 80%, 90%, and 100% ethanol and air drying.to identify deletions of 17p11.2, a region commonly
Probes were denatured at 707C for 10 min prior to place-deleted in SMS. All cosmids were grown in the appro-
ment on the slides. After the addition of glass coverslipspriate media supplemented with either ampicillin (50
sealed with rubber cement, the slides were hybridizedmg/ml final, for cosmids c102 and c106) or kanamycin
overnight at 377C in a humidified chamber.(25 mg/ml final, for the remaining cosmids) and were
purified by use of the Qiagen system of cosmid isolation.
Washing and Detection
Probe Labeling Hybridized slides were washed in a 50% formamide,
2 1 SSC solution for 15 min at 437C, followed by twoThe cosmid for DGS/VCFS was labeled by use of bio-
tin and were detected by use of avidin-FITC, producing 5-min washes in 2 1 SSC at 377C and a 3-min rinse (all
performed in coplin jars) in 4 1 SSC, 0.1% Tween-20a signal that fluoresced green. Probes for SMS and WS
were labeled with digoxigenin and were detected by use (final concentrations) at room temperature. Slides were
detected by the following steps: 60 ml (per slide) FITC-of anti-digoxigenin conjugated to rhodamine, which
fluoresced red. The probes for PWS/AS were combined avidin (Oncor), 20 min at 437C; 60 ml (per slide) mouse
anti-digoxigenin antibody diluted 1:250 in anti-avidin;in a 1:1 ratio of biotin- and digoxigenin-labeled cosmids.
After detection, this produced fluorescent yellow signals 60 ml (per slide) anti-mouse IgG-digoxigenin diluted
1:200 in TNB buffer (100 mM Tris pH 8.0, 150 mMon chromosome 15. For the nick-translation reactions,
1 mg of each cosmid DNA was labeled in a 40-ml reaction NaCl, 0.05% Tween 20, 0.5% blocking reagent [Boeh-
ringer Mannheim]); and 60 ml (per slide) anti-digoxi-containing 10 ml of dNTP mix (2.4 ml each of 10 mM
dATP, dCTP, and dGTP, 1.6 ml of 10 mM dTTP; 8.0 genin rhodamine (Boehringer Mannheim) diluted 1:100
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in FITC-avidin. Washes of 3 min as described above for a given probe (and therefore ‘‘positive’’ for the corre-
sponding gene-deletion syndrome) were found to be de-were performed between each detection/amplification
step. Metaphases were visualized after being counter- leted for that probe in each of the 20 metaphases scored.
By MultiFISH, 11 of the 200 samples analyzed werestained with DAPI.
found to have a deletion. When samples were decoded,
Scoring it was found that 10 of the 11 samples deleted for a
probe had been submitted to the cytogenetics laboratoryTwenty metaphases were scored for each slide. For
for analysis by FISH and had been identified in paralleleach metaphase the presence or absence of four sets of
as being deleted, by use of single-probe FISH. As dis-homologous signals was scored: two sets of yellow sig-
cussed below, MultiFISH also identified one patient withnals on chromosome 15 (for PWS/AS); two sets of red
a deletion of the DGS/VCFS region. Single-probe FISHsignals on chromosome 7 (for WS); two sets of red sig-
was subsequently performed and confirmed the deletion.nals on chromosome 17 (for SMS), distinguishable from
After the MultiFISH scoring was complete, indica-chromosome 7 on the basis of size and morphology; and
tions for cytogenetic referral were matched to the indi-two sets of green signals on chromosome 22 (for DGS/
vidual patients via the laboratory identification num-VCFS). In a small fraction of samples, one homologue
bers. The majority (189/200) of patients screened wereof a chromosome pair would not fluoresce in a given
not found to be deleted for any of the tested loci. Thismetaphase. However, scoring of additional metaphases,
category included the 154 patients (77.0%) referred forfor a total of 20, would then confirm that no deletion
reasons other than to rule out a specific deletion (tablewas present. Patients who were deleted for a particular
1). A representative normal MultiFISH result, in which alllocus were deleted for a single homologue in each of the
signals are present, is shown in figure 2. For patients not20 cells (100% of metaphases) scored.
deleted for any of the tested loci, a total of eight signals
Digital-Imaging Microscopy could be visualized, whereas only seven signals were ob-
served in patients deleted for one of the tested loci.Metaphase chromosomes were visualized, and the
Forty-five of the samples (22.5%) included in the sur-MultiFISH results were scored on a Zeiss Axiophot flu-
vey were referred for analysis of a specific microdeletion.orescence microscope using a triple-bandpass filter. This
Thirty-five of these cases were found to be nondeletedallowed the simultaneous visualization of the different-
for the tested loci both by MultiFISH and by single-colored signals included in the MultiFISH cocktail. Digi-
probe FISH. All cases found to be deleted for the testedtal images were obtained with the use of a Perceptive
loci by independent single FISH studies were also de-Scientific Instruments Powergene 810 probe system.
tected by MultiFISH analysis. In all 10 of these cases,Captured images were then printed on a Tektronix
the clinical cytogenetics laboratory had identified a dele-Color/Monochrome Phasar II SDX printer.
tion by using the appropriate single-probe FISH. Each
case was also simultaneously submitted for blinded anal-Results
ysis by MultiFISH. In no instance was any patient incor-
rectly classified as deleted for the tested loci (i.e., thereTwo hundred cultured lymphocyte samples were
screened by use of the MultiFISH cocktail of probes, were no false positives) by MultiFISH. This result dem-
onstrates that individual deletions identified by use ofwhich included single cosmids as well as cosmid contigs.
The indications for chromosomal studies in each of these MultiFISH are consistent with the results obtained by
use of traditional, single-probe FISH.cases were either to exclude specific microdeletion syn-
dromes by FISH (e.g., PWS or SMS) or to assess the In order to establish a new diagnostic procedure for
use in a cytogenetics laboratory, analytical sensitivitypossibility of a chromosomal basis for features including
developmental delay, mental retardation, dysmorphic and specificity must first be determined. The analytical
sensitivity for this assay is the probability that the testfacies and/or multiple congenital anomalies (table 1). All
patients received a routine chromosome analysis (n will detect a deletion when a deletion is truly present
(Leaverton 1991, pp. 7–27). For MultiFISH, this can 200) and, if requested in the referral, a specific FISH
assay for a suspected microdeletion, by use of the rele- be calculated by use of the known deletion-patient sam-
ples that were entered into this study. The appropriatevant individual FISH probes (n  45). At the time of
the routine cytogenetic study, additional slides were deletion was detected in 100% of 11 specimens with
known deletions, when the MultiFISH assay was used;made and submitted for MultiFISH analysis. In each
case, the MultiFISH samples were scored in a blinded therefore, the sensitivity of this test, as measured in this
population of samples, is 100%.fashion, and 20 metaphases per patient were scored.
Since this assay was not designed to address the issue The analytical specificity for this assay is the probabil-
ity of scoring a sample as a nondeletion when a deletionof mosaicism, patients were scored as either deleted or
not deleted for a particular probe. All patients deleted is truly not present (i.e., when there are two normal
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Figure 2 Representative normal MultiFISH result. Signals correspond to critical regions for the following syndromes: WS, chromosome
7 (nl 7 [red]), DGS/VCFS, chromosome 22 (nl 22 [green]), PWS/AS, chromosome 15 (nl 15 [yellow]), and SMS, chromosome 17 (nl 17 [red]).
chromosomes) (Leaverton 1991, pp. 7–27). All cases son with single-probe FISH, hybridization efficiency was
not compromised in MultiFISH. Furthermore, for thescored as deleted for the tested loci had their respective
deletions confirmed by use of single-probe FISH; thus, individuals deleted for the tested loci (n  11), we used
their ‘‘nondeleted’’ chromosomes to calculate the hy-on a patient-result basis, the specificity was 100%. For
FISH, specificity on a per-chromosome basis provides a bridization efficiency (expected number of hybridization
signals is seven). The hybridization efficiency of eachmeasure of hybridization efficiency. The hybridization
efficiency was calculated in two ways, by use of the data probe ranged from 98.6% (WS probe) to 99.3% (PWS/
AS probe), with 98.9% being the overall collective hy-for individual probes and by use of the data for pooled
probes, for the nondeletion group of patients and the bridization efficiency of the MultiFISH assay. There was
deletion group of patients. The results are shown in table
2. First, the hybridization efficiency of each individual
probe was calculated for the nondeletion individuals (n Table 2
 189). The calculated hybridization efficiencies were
Probe Specificity94.7% (WS probe), 96.7% (DGS/VCFS probe), 96.9%
(SMS probe), and 98.0% (PWS/AS probe). Furthermore, NO. OF SIGNALS OBSERVED/
the combined overall hybridization efficiency of the NO. OF SIGNALS EXPECTED (%)
MultiFISH assay was determined to be 96.6%. This
Patients Not Deleted Patients Deletednumber indicates that 96% of metaphases scored had
for Probea for Probeball eight signals and that 4% of cells analyzed had
fewer than eight (i.e., either six or seven) signals. For WS 7,157/7,560 (94.7) 355/360 (98.6)
purposes of comparison, each individual cosmid (or cos- PWS/AS 7,410/7,560 (98.0) 417/420 (99.3)
DGS/VCFS 7,309/7,560 (96.7) 395/400 (99.2)mid contig) was also hybridized to normal cells from
SMS 7,329/7,560 (96.9) 357/360 (98.8)four control individuals, and a total of 100 metaphases/
All loci 29,205/30,240 (96.6) 1,524/1,540 (98.9)probe were scored, in order to calculate probe hybridiza-
tion efficiencies. The following results were observed: a Maximum signals possible per patient is 8.
94% (WS probe), 97% (DGS/VCFS probe), 98% (SMS b Does not include deleted chromosome (i.e., maximum number of
signals per patient is 7).probe), and 98% (PWS/AS probe). Clearly, by compari-
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a significant difference, in probe hybridization efficiency, leted regions. Typically, FISH analysis using a single
probe is performed when a clinician suspects a particularbetween the individual probes within the group not de-
leted for the tested loci (x23  39.87, P  .0001) but not microdeletion or contiguous gene–deletion syndrome in
a patient. Ideally, the results of FISH analysis provide awithin the group deleted for the tested loci (x23  0.17,
P  .99). This discrepancy may be due to sample size. molecular cytogenetic confirmation of a clinical diagno-
sis that is already suspected by the physician. However,Regardless, these differences did not affect the overall
ability of this assay to discriminate between samples making such a diagnosis is often complicated when a
patient presents with nonspecific or nondiagnostic find-deleted for the tested loci and samples not deleted for
the tested loci. ings, such as mental retardation or global developmental
delay. This problem is evidenced in table 1, which in-Finally, the MultiFISH assay identified a deletion in
the DGS/VCFS region in a single patient whose karyo- cludes seven cases, each referred to exclude multiple ge-
netic syndromes that can include developmental delaytype was apparently normal. This particular patient was
referred for chromosomal analysis because of develop- as a component. Furthermore, as a specific example,
patient C (fig. 1) was referred to the clinical cytogeneticsmental delay and mental retardation. Since no specific
disorder had been suspected by the clinician, a FISH laboratory to be evaluated for both PWS and WS. Subtle
facial features were suggestive of both PWS (almond-analysis to rule out any microdeletions had not been
requested. Analysis of this sample by MultiFISH showed shaped eyes) and WS (full lips). Although this patient’s
short stature was suggestive of either of these syn-hybridization of the F5 probe to only a single chromo-
some 22 homologue in 100% of the metaphases exam- dromes, his obesity was certainly more typical of PWS
(for the correct diagnosis, see the appendix).ined. By use of the single F5 cosmid probe corresponding
to the DGS/VCFS commonly deleted region, the results Here we have described the identification of a DGS/
VCFS deletion through MultiFISH. Although a physicalof MultiFISH for this patient were subsequently con-
firmed. exam of this 2-year-old child did identify some dys-
morphism (flat nasal bridge, broad forehead, and hyper-
telorism), no features that were particularly suggestiveDiscussion
of VCFS were present. Routine cytogenetic analysis of
this child resulted in an apparently normal G-bandedGeneticists have been well served by diagnostic tests
that detect a large number of disorders, as exemplified karyotype, and, since the clinician did not suspect any
deletion syndrome, an appropriate FISH analysis wasby banded karyotype analysis, amino acid analysis, and
organic acid analysis. It would be desirable to increase not performed. However, analysis of this child by use
of MultiFISH identified a deletion at the DGS/VCFSthe general sensitivity of chromosomal analysis, in order
to detect the large number of known microdeletion syn- critical region. Discovery of the deletion provided this
family with a diagnosis and potentially avoided a greatdromes and to detect as yet undiscovered microdele-
tions. Three diagnostic difficulties exist: first, some of deal of time and expense in additional testing to deter-
mine a cause for this child’s developmental delay. As athe syndromes do not have distinct and consistent fea-
tures that can guide the clinician toward requesting a result, appropriate medical evaluation can now be ob-
tained, potential future complications of this disease canspecific diagnostic test; second, variability in the clinical
presentation, such as subtle or atypical features as exem- now be predicted, and recurrence-risk estimates can be
made for the parents. For VCFS in particular, MultiFISHplified in figure 1, may lead to underrecognition of cer-
tain disorders; and, third, many clinical evaluations are can potentially be very useful in the identification of
affected individuals, since the physical features are notperformed by neurologists, cardiologists, geneticists,
and other clinicians, who may not be as experienced always conspicuous enough to allow a diagnosis; this is
especially true in young children (Lindsay et al. 1995)as a skilled dysmorphologist in recognizing subtle or
nonspecific features. This problem is especially relevant and in children of varied ethnicities. It is precisely this
type of patient for whom the MultiFISH analysis wouldin the case of very young infants, for whom the charac-
teristic features of a disease may not yet have manifested be most beneficial.
There are many microdeletion syndromes for whichand in whom developmental delay and/or mental retar-
dation cannot be adequately assessed. Although various critical or commonly deleted regions have been identified
and for which good-quality FISH probes have been de-strategies are being explored to increase the detection
of microdeletions, pooled probes for MultiFISH analysis veloped. These syndromes include the disorders being
assayed with this first version of a MultiFISH deletioncould represent one attractive approach to this complex
diagnostic problem. detection panel: PWS, AS, WS, DGS/VCFS, SMS, and
Miller-Dieker syndrome, which was not represented inWe have demonstrated that multiple probes hybrid-
ized concomitantly in a FISH analysis can be useful in MultiFISH (Kuwano et al. 1991, 1992; Desmaze et al.
1993; Ewart et al. 1993; Lindsay et al. 1993; Chen etthe simultaneous examination of several frequently de-
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al. 1995; reviewed in Shaffer 1995). When any of these It should be noted, for example, that not all patients
with mutations at critical genes involved in contiguousconditions is suspected in a patient, FISH analysis using
the appropriate probe is frequently used to confirm the gene–deletion syndromes will have deletions. For exam-
ple, only 70% of PWS patients are deleted for a paternaldiagnosis. However, if more than one such syndrome is
to be tested for deletions, then multiple sequential FISH copy of chromosome 15q11-q13 (American Society of
Human Genetics/American College of Medical Geneticsanalyses must be performed. In contrast, cohybridiza-
tion of several critical-region probes saves time, requires Test and Technology Transfer Committee 1996). Of the
remaining cases, 28% show maternal uniparental dis-less sample material and fewer slides, and allows for
simultaneous analysis of some of the more common omy, and 2% will have a mutation affecting the im-
printing center (American Society of Human Genetics/gene-deletion syndromes. Hybridization of probes la-
beled in different color combinations, as described here, American College of Medical Genetics Test and Tech-
nology Transfer Committee 1996). Although both offurther facilitates analysis by fluorescent microscopy,
when coupled with a triple-bandpass filter. the latter mechanisms can preclude expression from the
paternal PWS allele, neither type of mutation will beEstablishing a new FISH test in a diagnostic cytoge-
netic laboratory requires that the assay demonstrate ascertained by use of this type of FISH analysis. These
cases will ultimately require molecular studies (i.e., par-both analytical sensitivity and specificity. By examining
the efficacy of individual FISH probes versus the ent-of-origin studies and methylation studies), in order
to allow the mutation to be uncovered. Additionally,MultiFISH assay as performed here, we have shown that
neither sensitivity nor specificity has been compromised; rare patients with small, atypical deletions may not be
ascertained by MultiFISH, since detection requires thatboth were 100%. The hybridization efficiency (i.e., the
percent of normal metaphases in which all four sets of probes be located entirely within the deleted regions.
Clearly, MultiFISH can identify only deletions forsignals could be visualized) of MultiFISH was 96%–
99%. When all eight signals could not be seen, it was which the specific probes have been included. The con-
stitution of the probe cocktail may of course be adjustedtypically a single signal that was absent (this occurred
in the remaining 4% of metaphases examined). More to reflect other deletion syndromes of interest, as long
as specific, good-quality probes are available. Therefore,remarkably, however, each of the cases deleted for the
tested loci demonstrated hybridization of only a single MultiFISH can be considered only as reliable as its con-
stituent probes. It might be argued that clinicians canhomologue in 100% of the metaphases examined. Cer-
tainly, as in FISH analyses using single probes, good- suspect the diagnoses in question and order the appro-
priate, specific tests, thereby making a screening diag-quality slides with many metaphases allow for clearer
interpretation of the results. nostic approach inappropriate. We believe that this per-
spective is flawed, for multiple reasons: (1) itThe MultiFISH assay should be viewed as a screening
tool that increases one’s ability to detect chromosomal overestimates the ability of even the best clinicians to
diagnose the recognizable syndromes, as evidenced byabnormalities. As such, a normal MultiFISH analysis
does not exclude the possibility of other chromosome figure 1; (2) current practices may diagnose typical clini-
cal cases and fail to diagnose atypical cases, so that theabnormalities and should therefore be performed in con-
junction with routine cytogenetics. This is evidenced by full clinical spectrum for some disorders may be pres-
ently unknown; (3) many physicians evaluating develop-the finding of chromosome anomalies—such as trisomy
21, fragile X, del(13)(q21q32), and inv(20)(q12q13.3)— mentally delayed infants and children are not experi-
enced dysmorphologists; (4) there are syndromes thatthrough routine cytogenetic analyses in certain cases of
the 200 included in this study. Clearly, chromosome simply cannot be recognized clinically in a consistent
manner yet are easily diagnosed by laboratory testinganalysis has a great advantage of uncovering gross ab-
normalities, since the whole genome is assessed. In the (e.g., SMS) (Greenberg et al. 1996); (5) cytogenetic labo-
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gram. of disorders that can be especially difficult to diagnose
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